Literature DB >> 10722680

Mechanism of insulin resistance in A-ZIP/F-1 fatless mice.

J K Kim1, O Gavrilova, Y Chen, M L Reitman, G I Shulman.   

Abstract

Insulin resistance is a major factor in the pathogenesis of type 2 diabetes and may be related to alterations in fat metabolism. Fatless mice have been created using dominant-negative protein (A-ZIP/F-1) targeted gene expression in the adipocyte and shown to develop diabetes. To understand the mechanism responsible for the insulin resistance in these mice, we conducted hyperinsulinemic-euglycemic clamps in awake fatless and wild type littermates before the development of diabetes and examined insulin action and signaling in muscle and liver. We found the fatless mice to be severely insulin-resistant, which could be attributed to defects in insulin action in muscle and liver. Both of these abnormalities were associated with defects in insulin activation of insulin receptor substrate-1 and -2-associated phosphatidylinositol 3-kinase activity and a 2-fold increase in muscle and liver triglyceride content. We also show that upon transplantation of fat tissue into these mice, triglyceride content in muscle and liver returned to normal as does insulin signaling and action. In conclusion, these results suggest that the development of insulin resistance in type 2 diabetes may be due to alterations in the partitioning of fat between the adipocyte and muscle/liver leading to accumulation of triglyceride in the latter tissues with subsequent impairment of insulin signaling and action.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722680     DOI: 10.1074/jbc.275.12.8456

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  137 in total

1.  Unraveling the mechanism of action of thiazolidinediones.

Authors:  C R Kahn; L Chen; S E Cohen
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 2.  Cellular mechanisms of insulin resistance.

Authors:  G I Shulman
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

3.  Prevention of fat-induced insulin resistance by salicylate.

Authors:  J K Kim; Y J Kim; J J Fillmore; Y Chen; I Moore; J Lee; M Yuan; Z W Li; M Karin; P Perret; S E Shoelson; G I Shulman
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 4.  Ectopic fat accumulation: an important cause of insulin resistance in humans.

Authors:  Hannele Yki-Järvinen
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

5.  Cellular mechanism of insulin resistance in skeletal muscle.

Authors:  Kitt Falk Petersen; Gerald I Shulman
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

6.  Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-deficient mice.

Authors:  S Z Duan; M G Usher; E L Foley; D S Milstone; F C Brosius; R M Mortensen
Journal:  Diabetologia       Date:  2010-04-17       Impact factor: 10.122

7.  Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance.

Authors:  Cheol Soo Choi; Jonathan J Fillmore; Jason K Kim; Zhen-Xiang Liu; Sheene Kim; Emily F Collier; Ameya Kulkarni; Alberto Distefano; Yu-Jin Hwang; Mario Kahn; Yan Chen; Chunli Yu; Irene K Moore; Richard M Reznick; Takamasa Higashimori; Gerald I Shulman
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

Review 8.  Immune cells and metabolic dysfunction.

Authors:  Ashley Eheim; Dasa Medrikova; Stephan Herzig
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

Review 9.  The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function.

Authors:  Gijs H Goossens
Journal:  Obes Facts       Date:  2017-06-01       Impact factor: 3.942

10.  Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance.

Authors:  C Guerra; P Navarro; A M Valverde; M Arribas; J Brüning; L P Kozak; C R Kahn; M Benito
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.